Verzenio is a prescription medicine containing abemaciclib that may be used as part of treatment for certain people with hormone receptor positive and HER2 negative breast cancer. Before starting treatment, it is important to understand how the medicine works, how it is taken, possible side effects.
Verzenio, also known by its generic name abemaciclib, is a targeted medicine called a CDK4/6 inhibitor. It works by blocking proteins that help certain cancer cells grow and divide. It is used for specific types of hormone receptor positive and HER2 negative breast cancer. Before treatment begins, patients should understand the intended use, dosing instructions, monitoring requirements, and potential risks.
Verzenio may be prescribed alone or alongside hormone therapy, depending on the patient's diagnosis and treatment plan. Because individual circumstances vary, the healthcare professional prescribing the medicine determines whether it is appropriate and how it should be used.
Important things to understand before starting include:
Understanding these factors beforehand can make it easier to follow the prescribed treatment plan and identify concerns early.
Like other prescription medicines, Verzenio can cause side effects. Some are relatively common, while others may require prompt medical attention. Regular monitoring may include blood tests to check blood cell counts and liver function.
Potential concerns include:
Before starting Verzenio, understanding its purpose, dosing instructions, possible side effects, medication interactions, and monitoring requirements is important. Patients should communicate openly with their healthcare team and report unusual or worsening symptoms rather than making treatment changes independently. This information is intended for general educational purposes only and does not replace advice from a qualified healthcare professional. Verzenio should be used only according to the treatment plan prescribed by the appropriate medical team.